R. Todd Joyce is CFO-Global & PAO at WATSON PHARMACEUTICALS INC (WPI). They have made 10 open-market trades across 2 companies since 2010, most recently 2014-05-09.
CIK 0001242066
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACT | SELL | 2013-12-06 | 2013-12-06 | $165.83 | $2.4M | +0.0% | +0.0% | +0.0% |
| ACT | SELL | 2013-11-05 | 2013-11-07 | $157.48 | $3.5M | +0.0% | +0.0% | +0.0% |
| ACT | SELL | 2013-08-14 | 2013-08-15 | $137.98 | $2.1M | +0.0% | +0.0% | +0.0% |
| WPI | SELL | 2012-08-01 | 2012-08-01 | $78.60 | $772K | N/A | N/A | N/A |
| WPI | SELL | 2011-08-24 | 2011-08-26 | $65.46 | $624K | N/A | N/A | N/A |
| WPI | SELL | 2011-07-27 | 2011-07-28 | $68.41 | $493K | N/A | N/A | N/A |
| WPI | SELL | 2011-05-04 | 2011-05-05 | $62.91 | $504K | N/A | N/A | N/A |
| WPI | SELL | 2011-03-03 | 2011-03-07 | $57.09 | $627K | N/A | N/A | N/A |
| WPI | SELL | 2010-12-14 | 2010-12-15 | $49.60 | $496K | N/A | N/A | N/A |
| WPI | SELL | 2010-12-10 | 2010-12-14 | $49.00 | $123K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.